Synapse - Favorable outcomes of patients with limited-stage ocular adnexal DLBCL treated in the rituximab era: Long-term follow-up of a single center experience

Favorable outcomes of patients with limited-stage ocular adnexal DLBCL treated in the rituximab era: Long-term follow-up of a single center experience Meeting Abstract

Authors:	Qualls, D.; Batlevi, C. L.; Caron, P. C.; Hamilton, A.; Hamlin, P. A.; Horwitz, S. M.; Joffe, E.; Khan, N.; Kumar, A.; Matasar, M. J.; Moskowitz, A. J.; Noy, A.; Owens, C.; Palomba, M. L.; Straus, D. J.; von Keudell, G.; Zelenetz, A. D.; Okwali, M.; Yahalom, J.; Schöder, H.; Dogan, A.; Salles, G.; Falchi, L.
Abstract Title:	Favorable outcomes of patients with limited-stage ocular adnexal DLBCL treated in the rituximab era: Long-term follow-up of a single center experience
Meeting Title:	63rd Annual Meeting of the American Society of Hematology (ASH)
Journal Title:	Blood
Volume:	138
Issue:	Suppl. 1
Meeting Dates:	2021 Dec 11-14
Meeting Location:	Atlanta, GA
ISSN:	0006-4971
Publisher:	American Society of Hematology
Date Published:	2021-11-23
Language:	English
ACCESSION:	WOS:000835740102054
DOI:	10.1182/blood-2021-153171
PROVIDER:	wos
Notes:	Meeting Abstract: 4578 -- Hybrid meeting, also took place online -- Source: Wos